Accordo trips, brevetti e resistenze interne in India: uno scenario frastagliato
Abstract
This paper deals with the “difficult relationship” between India and pharmaceutical patents. Throughout the article, the strictly juridical dimension of the problem is let on the background. The aim is to highlight the multifarious, complex and stratified reasons of Indian resistance towards a strong intellectual property protection for medicines. The roots of said behavior go from cultural motives to pharmaceutical industries’ unfair practices, from sanitarian and humanitarian aspects to the peculiar social and economic Indian situation.
Downloads
Download data is not yet available.
The articles that have appeared on Kervan since 2016 are rated as Class A in the system of National Scientific Qualification (ASN, disciplines 10/N1 and 10/N3).
Indexed by 
The journal has been approved for inclusion in DOAJ. The DOAJ listing of the journal is available at 
The journal has been approved for inclusion in ERIH PLUS. The ERIH PLUS listing of the journal is available at 
Kervan was just accepted for indexing in SCOPUS. This important milestone ensures that articles published in Kervan are easily found when searching for library, archives and Information science and it enables Kervan authors to keep track of how often their article has been cited by others.
